Fewer actionable mutations but higher tumor mutational burden characterizes NSCLC in black patients at an urban academic medical center.

Choudhury, Noura J; Eghtesad, Mansooreh; Kadri, Sabah; Cursio, John; Ritterhouse, Lauren; Segal, Jeremy; Husain, Aliya; Patel, Jyoti D

Choudhury, Noura J; Eghtesad, Mansooreh; Kadri, Sabah; Cursio, John; Ritterhouse, Lauren; Segal, Jeremy; Husain, Aliya; Patel, Jyoti D.

Afiliación

Choudhury NJ; Department of Medicine, The University of Chicago, Chicago, Illinois, USA.
Eghtesad M; Department of Pathology, Advocate Illinois Masonic Medical Center, Chicago, Illinois, USA.
Kadri S; Department of Pathology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
Cursio J; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA.
Ritterhouse L; Division of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
Segal J; Division of Genomic and Molecular Pathology, Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
Husain A; Department of Pathology, The University of Chicago, Chicago, Illinois, USA.
Patel JD; Department of Medicine, The University of Chicago, Chicago, Illinois, USA.

Oncotarget ; 10(56): 5817-5823, 2019 Oct 08.

Article en En | MEDLINE | ID: mdl-31645901

Palabras clave

biomarkers; healthcare disparities; immunotherapies; non-small cell lung cancer; targeted therapies

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Aspecto: Equity_inequality Idioma: En Revista: Oncotarget Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google